Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

Key finding

Method / model

Relevance

Frías, J.P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. NEJM, 385(6), 503-515.